Apyx Medical Corporation was the subject of a securities class action settlement — captioned Pritchard v. Apyx Medical Corp. — covering purchasers of the company's common stock or options during the class period. The $3,000,000 cash settlement was available to stockholders and options traders who experienced losses, though the claim deadline of December 16, 2020, has now passed. This record is maintained for historical reference.